Shares of hVIVO plc (LON:HVO – Get Free Report) crossed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 26.82 ($0.33) and traded as low as GBX 20 ($0.25). hVIVO shares last traded at GBX 20.50 ($0.25), with a volume of 933,350 shares traded.
hVIVO Price Performance
The firm has a market cap of £129.95 million, a P/E ratio of 636.67 and a beta of 0.97. The company has a current ratio of 1.61, a quick ratio of 1.16 and a debt-to-equity ratio of 33.86. The business has a 50-day moving average price of GBX 23.39 and a 200-day moving average price of GBX 26.71.
About hVIVO
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
See Also
- Five stocks we like better than hVIVO
- What is Forex and How Does it Work?
- Insiders Are Selling, But These 3 Stocks Are Must-Buys
- What is the Hang Seng index?
- Rivian Defies Doubters: Delivery Triumph Fuels Stock Surge
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Hindenburg Short Report Slams Carvana Over Alleged ‘Grift’
Receive News & Ratings for hVIVO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for hVIVO and related companies with MarketBeat.com's FREE daily email newsletter.
